Dimensional Fund Advisors
JUNO

Dimensional Fund Advisors’s Juno Therapeutics, Inc. JUNO Stock Holding History

Dimensional Fund Advisors’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-495,103
Closed -$22.6M – 3382
2017
Q4 		$22.6M Buy
495,103
+102,129
+26% +$5.09M 0.01% 2001
2017
Q3 		$17.6M Buy
392,974
+204,493
+108% +$6.97M 0.01% 2120
2017
Q2 		$5.63M Buy
+188,481
New +$4.65M ﹤0.01% 2540
2016
Q4 		– Sell
-9,312
Closed -$279K – 3319
2016
Q3 		$279K Buy
+9,312
New +$290K ﹤0.01% 3148

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Dimensional Fund Advisors's JUNO Position: Q1 2018 in Review

Dimensional Fund Advisors sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 495,103 shares — an estimated $22.6M sold.

Dimensional Fund Advisors first reported a position in JUNO in Q3 2016 and held it in 4 quarters. The position peaked at $22.6M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Dimensional Fund Advisors reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Dimensional Fund Advisors sold 495,103 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $22.6M.
  • Dimensional Fund Advisors first reported a position in Juno Therapeutics, Inc. in Q3 2016 and held it in 4 quarters.
  • Dimensional Fund Advisors's Juno Therapeutics, Inc. position peaked at $22.6M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Dimensional Fund Advisors's 13F filing for Q1 2018, filed 11 May 2018.